Strides Pharma Science informs about press release

02 Aug 2023 Evaluate
Strides Pharma Science has informed that it enclosed Press Release (along with Earnings presentation) issued by the Company titled: ‘Strides reports highest ever EBITDA, INR 1,686m in Q1FY24’.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

899.65 -2.70 (-0.30%)
01-Jan-2026 10:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1710.85
Dr. Reddys Lab 1253.65
Cipla 1503.15
Zydus Lifesciences 910.00
Lupin 2083.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×